Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DSGN

Design Therapeutics (DSGN)

Design Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DSGN
DateTimeSourceHeadlineSymbolCompany
09/05/202406:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DSGNDesign Therapeutics Inc
09/05/202406:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DSGNDesign Therapeutics Inc
09/05/202406:05GlobeNewswire Inc.Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program MilestonesNASDAQ:DSGNDesign Therapeutics Inc
07/05/202420:30GlobeNewswire Inc.Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare ConferenceNASDAQ:DSGNDesign Therapeutics Inc
20/03/202407:01GlobeNewswire Inc.Design Therapeutics Outlines Progress Across GeneTACâ„¢ Platform and Announces Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:DSGNDesign Therapeutics Inc
19/03/202422:27IH Market NewsUS Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices RetreatNASDAQ:DSGNDesign Therapeutics Inc
12/03/202421:30GlobeNewswire Inc.Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio UpdateNASDAQ:DSGNDesign Therapeutics Inc
06/01/202408:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DSGNDesign Therapeutics Inc
06/01/202408:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DSGNDesign Therapeutics Inc
06/12/202310:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DSGNDesign Therapeutics Inc
14/11/202308:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DSGNDesign Therapeutics Inc
14/11/202308:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DSGNDesign Therapeutics Inc
14/11/202308:05GlobeNewswire Inc.Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portfolio Update in Early 2024NASDAQ:DSGNDesign Therapeutics Inc
07/09/202307:13Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:DSGNDesign Therapeutics Inc
31/08/202308:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DSGNDesign Therapeutics Inc
31/08/202308:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DSGNDesign Therapeutics Inc
26/08/202307:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DSGNDesign Therapeutics Inc
15/08/202306:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DSGNDesign Therapeutics Inc
15/08/202306:05GlobeNewswire Inc.Design Therapeutics Provides Pipeline Update and Reports Second Quarter 2023 Financial ResultsNASDAQ:DSGNDesign Therapeutics Inc
15/08/202306:01GlobeNewswire Inc.Design Therapeutics Reports Initial Results from Phase 1 Multiple-Ascending Dose Study of DT-216 for the Treatment of Friedrich AtaxiaNASDAQ:DSGNDesign Therapeutics Inc
03/06/202306:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DSGNDesign Therapeutics Inc
03/06/202306:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DSGNDesign Therapeutics Inc
03/06/202306:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DSGNDesign Therapeutics Inc
03/06/202306:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DSGNDesign Therapeutics Inc
03/06/202306:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DSGNDesign Therapeutics Inc
03/06/202306:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DSGNDesign Therapeutics Inc
02/06/202306:46Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DSGNDesign Therapeutics Inc
31/05/202320:30GlobeNewswire Inc.Design Therapeutics to Present at the 2023 Jefferies Healthcare ConferenceNASDAQ:DSGNDesign Therapeutics Inc
10/05/202306:14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DSGNDesign Therapeutics Inc
10/05/202306:05GlobeNewswire Inc.Design Therapeutics Provides Pipeline Updates and Reports First Quarter 2023 Financial ResultsNASDAQ:DSGNDesign Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:DSGN

Your Recent History

Delayed Upgrade Clock